Induced pluripotent stem cells (iPSCs) have radically advanced the field of regenerative medicine by making possible the production of patient-specific pluripotent stem cells from adult individuals. While cell differentiation protocols have been successfully developed, and animal models of human disease have proved that these cells have the potential to treat human diseases and conditions produced as a consequence of aging, degeneration, injury, and birth defects, logistical issues still remain unsolved and hamper the possibility of testing these cells in human clinical trials. Among them is the widely spread use of animal products for the generation and culture of iPSCs. We report here a xeno-free iPSC generation system that addresses all the steps of iPSCs production including the isolation and culture of adult skin fibroblasts, and iPSCs generation, expansion, and maintenance. iPSCs generated with a polycistronic lentiviral vector under xeno-free conditions displayed markers of pluripotency and gave rise to embryoid bodies (EBs) displaying indicators of the 3 primary germ layers. Xeno-free iPSCs injected into nude mice produced classic teratomas, and teratoma explants cultured under conditions favoring fibroblastic cells gave rise to cells morphologically indistinguishable from input cells. Protocols here described will facilitate the implementation of new cellular therapies for preclinical and clinical studies, potentially reducing the regulatory burden without compromising the differentiation potential of the cells.
Get full access to this article
View all access options for this article.
References
1.
GRMartin. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA, 78:7634–7638.
2.
EvansMJ, KaufmanMH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature, 292:154–156.
3.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS, JonesJM. 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
4.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK, YamanakaS. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
ParkIH, ZhaoR, WestJA, YabuuchiA, HuoH, InceTA, LerouPH, LenschMW, DaleyGQ. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451:141–146.
7.
LowryWE, RichterL, YachechkoR, PyleAD, TchieuJ, SridharanR, ClarkAT, PlathK. 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA, 105:2883–2888.
8.
HuangfuD, OsafuneK, MaehrR, GuoW, EijkelenboomA, ChenS, MuhlesteinW, MeltonDA. 2008. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol, 26:1269–1275.
9.
AasenT, RayaA, BarreroMJ, GarretaE, ConsiglioA, GonzalezF, VassenaR, BilicJ, PekarikV, TiscorniaG, EdelM, BouéS, BelmonteJC. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol, 26:1276–1284.
10.
HannaJ, WernigM, MarkoulakiS, SunCW, MeissnerA, CassadyJP, BeardC, BrambrinkT, WuLC, TownesTM, JaenischR. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318:1920–1923.
11.
WernigM, ZhaoJP, PruszakJ, HedlundE, FuD, SoldnerF, BroccoliV, Constantine-PatonM, IsacsonO, JaenischR. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA, 105:5856–5861.
12.
XuD, AlipioZ, FinkLM, AdcockDM, YangJ, WardDC, MaY. 2009. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci USA, 106:808–813.
13.
NelsonTJ, Martinez-FernandezA, YamadaS, Perez-TerzicC, IkedaY, TerzicA. 2009. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120:408–416.
14.
LeiT, JacobS, Ajil-ZaraaI, DubuissonJB, IrionO, JaconiM, FekiA. 2007. Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges. Cell Res, 17:682–688.
15.
Hisamatsu-SakamotoM, SakamotoN, RosenbergAS. 2008. Embryonic stem cells cultured in serum-free medium acquire bovine apolipoprotein B-100 from feeder cell layers and serum replacement medium. Stem Cells, 26:72–78.
16.
CerdanC, BendallSC, WangL, StewartM, WerbowetskiT, BhatiaM. 2006. Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells. Nat Med, 12:1113–1114author reply 1115.
17.
MartinMJ, MuotriA, GageF, VarkiA. 2005. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med, 11:228–232.
18.
MallonBS, ParkKY, ChenKG, HamiltonRS, McKayRD. 2006. Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol, 38:1063–1075.
19.
SwistowskiA, PengJ, HanY, SwistowskaAM, RaoMS, ZengX. 2009. Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS ONE, 4:e6233.
20.
OkunoT, NakayamaT, KonishiN, MichibataH, WakimotoK, SuzukiY, NitoS, InabaT, NakanoI, MuramatsuS, TakanoM, KondoY, InoueN. 2009. Self-contained induction of neurons from human embryonic stem cells. PLoS ONE, 4:e6318.
DimosJT, RodolfaKT, NiakanKK, WeisenthalLM, MitsumotoH, ChungW, CroftGF, SaphierG, LeibelR, GolandR, WichterleH, HendersonCE, EgganK. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321:1218–1221.
SakamotoN, TsujiK, MuulLM, LawlerAM, PetricoinEF, CandottiF, MetcalfJA, TavelJA, LaneHC, UrbaWJ, FoxBA, VarkiA, LunneyJK, RosenbergAS. 2007. Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood, 110:501–508.
25.
FDA. 2008. Guidance for FDA Reviewers and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Somatic Cell Therapy Investigational New Drug Applications (INDs)Rockville, MD: Guidance for FDA Reviewers and Sponsors, 1–39.
26.
RichardsM, FongCY, ChanWK, WongPC, BongsoA. 2002. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol, 20:933–936.
27.
Dijon-GrinandM, AssouS, NadalL, MonzoC, HamamahS, De VosJ. 2009. Derivation of human iPS supported by isogenic fibroblasts. Fertil Steril, 92:S172–S172.
28.
UngerC, GaoS, CohenM, JaconiM, BergstromR, HolmF, GalanA, SanchezE, IrionO, DubuissonJB, Giry-LaterriereM, SalmonP, SimonC, HovattaO, FekiA. 2009. Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells. Hum Reprod, 24:2567–2581.
29.
XuC, InokumaMS, DenhamJ, GoldsK, KunduP, GoldJD, CarpenterMK. 2001. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol, 19:971–974.
30.
AmitM, SharikiC, MarguletsV, Itskovitz-EldorJ. 2004. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod, 70:837–845.
31.
LiuY, SongZ, ZhaoY, QinH, CaiJ, ZhangH, YuT, JiangS, WangG, DingM, DengH. 2006. A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun, 346:131–139.
32.
LudwigTE, LevensteinME, JonesJM, BerggrenWT, MitchenER, FraneJL, CrandallLJ, DaighCA, ConardKR, PiekarczykMS, LlanasRA, ThomsonJA. 2006. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol, 24:185–187.
33.
LudwigTE, BergendahlV, LevensteinME, YuJ, ProbascoMD, ThomsonJA. 2006. Feeder-independent culture of human embryonic stem cells. Nat Methods, 3:637–646.
34.
RajalaK, HakalaH, PanulaS, AivioS, PihlajamäkiH, SuuronenR, HovattaO, SkottmanH. 2007. Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum Reprod, 22:1231–1238.
35.
DraperJS, SmithK, GokhaleP, MooreHD, MaltbyE, JohnsonJ, MeisnerL, ZwakaTP, ThomsonJA, AndrewsPW. 2004. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol, 22:53–54.
ChangCW, LaiYS, PawlikKM, LiuK, SunCW, LiC, SchoebTR, TownesTM. 2009. Polycistronic lentiviral vector for “hit and run” reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells, 27:1042–1049.
38.
ZhouW, FreedCR. 2009. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells, 27:2667–2674.
39.
YuJ, HuK, Smuga-OttoK, TianS, StewartR, SlukvinII, ThomsonJA. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324:797–801.
40.
CareyBW, MarkoulakiS, HannaJ, SahaK, GaoQ, MitalipovaM, JaenischR. 2009. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA, 106:157–162.
41.
SommerCA, StadtfeldM, MurphyGJ, HochedlingerK, KottonDN, MostoslavskyG. 2009. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27:543–549.
42.
ShaoL, FengW, SunY, BaiH, LiuJ, CurrieC, KimJ, GamaR, WangZ, QianZ, LiawL, WuWS. 2009. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res, 19:296–306.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
